Although the cause of multiple myeloma is not known, research shows that genetic changes in the DNA of a single plasma cell ...

Multiple myeloma is a type of blood cancer that forms in plasma cells, white blood cells that produce infection-fighting antibodies. Multiple myeloma is not hereditary, meaning it is not passed ...

Multiple myeloma is a rare type of blood cancer that starts in your plasma cells. Your plasma cells are a type of white blood cell inside your bone marrow, the soft inner part of your bones.

After being diagnosed with multiple myeloma, Valarie Traynham turned her journey into a mission—raising awareness, educating ...

Regeneron Pharmaceuticals, Inc. REGN obtained positive opinion for its pipeline candidate linvoseltamab from the European ...

Follow along on our guide to Multiple Myeloma, a cancer of the bone marrow's infection-fighting plasma cells. As cancerous ...

Many products right now in clinical trials are showing promise in treating myeloma, especially with CAR T-cell therapy. So one product that I'm really excited about is the CAR T-cell product that ...

Dr. Usmani has more than 15 years of experience specializing in the care of patients with multiple myeloma and other disorders affecting plasma cells. Here Dr. Usmani discusses the current outlook for ...

A longitudinal multiomics analysis of a patient with multiple myeloma who developed peripheral T cell lymphoma after treatment with anti-BCMA CAR T cells and a GPRC5D-directed bispecific antibody ...

Here’s my take on myeloma-related studies that I’m excited about now and in the year ahead, with a focus on smoldering multiple myeloma (SMM), newly diagnosed disease, and first relapse.

A case in point is Mission Bio, a U.S-based biotechnology company that in June 2024, launched Tapestri Single-cell Multiple Myeloma Multiomics Solution, enabling comprehensive profiling of ...